NICE does not recommend Krystexxa (Savient Pharma) for …

See: "Improved Health-related Quality of Life and Physical Function in Patients with Refractory Chronic Gout Following Treatment with Pegloticase: Evidence from Phase III Randomized Controlled Trials ." Vibeke Strand et al.

More here: 
NICE does not recommend Krystexxa (Savient Pharma) for …

No comments yet.

TOP